Tuberculosis Research Units (P01 Clinical Trial Optional)
Funding is available to create multidisciplinary Tuberculosis Research Units that will work together as a network. Their mission is to better understand how Mycobacterium tuberculosis interacts with the human host by studying how differences among bacteria and among people influence infection outcomes and disease progression. The units will identify key bacterial and host factors that drive TB…
The purpose of this notice of funding opportunity (NOFO) is to support the establishment of multidisciplinary Tuberculosis (TB) Research Units (TBRUs) that will operate as a collaborative network to improve understanding of Mycobacterium tuberculosis (Mtb)-host interactions through characterizin…
Source
Awards & funding
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving…
Tags
Supporting links
Documents
Similar opportunities
-
Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed)
-
Notice of Special Interest (NOSI): Advancing Biomedical Research in Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections
-
Notice of Special Interest (NOSI): Establishing and Utilizing Pre-Clinical Animal Models to Study Post-TB Lung Disease Development
-
Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
-
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed)